3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Microsatellite Stable Rectal Carcinoma
1
Melanoma
1
Lymphoma
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Adenocarcinoma Of Esophagus
1
Interventions
Oxaliplatin
9
Capecitabine
9
Paclitaxel
7
Fluorouracil
7
pembrolizumab
6
Leucovorin
6
Cisplatin
5
zolbetuximab
4
Docetaxel
4
trastuzumab deruxtecan
3
enzalutamide
3
durvalumab
3
cemiplimab
3
Trastuzumab
3
Nivolumab
3
Irinotecan
3
Gemcitabine
3
Albumin-Bound Paclitaxel
3
fludarabine
2
darolutamide
2
atezolizumab
2
Taxes
2
Ramucirumab
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Pemetrexed
2
Cyclophosphamide
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
balstilimab
×
90 days
×
Clear all
No trials found.